Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Brian Bacskai, Ph.D.

Co-Author

This page shows the publications co-authored by Brian Bacskai and Steven Greenberg.
Connection Strength

2.429
  1. In vivo characterization of spontaneous microhemorrhage formation in mice with cerebral amyloid angiopathy. J Cereb Blood Flow Metab. 2021 01; 41(1):82-91.
    View in: PubMed
    Score: 0.222
  2. Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways. Nat Rev Neurol. 2020 01; 16(1):30-42.
    View in: PubMed
    Score: 0.220
  3. Vasomotion as a Driving Force for Paravascular Clearance in the Awake Mouse Brain. Neuron. 2020 02 05; 105(3):549-561.e5.
    View in: PubMed
    Score: 0.219
  4. Different microvascular alterations underlie microbleeds and microinfarcts. Ann Neurol. 2019 08; 86(2):279-292.
    View in: PubMed
    Score: 0.212
  5. Histopathology of diffusion imaging abnormalities in cerebral amyloid angiopathy. Neurology. 2019 02 26; 92(9):e933-e943.
    View in: PubMed
    Score: 0.207
  6. Emerging concepts in sporadic cerebral amyloid angiopathy. Brain. 2017 Jul 01; 140(7):1829-1850.
    View in: PubMed
    Score: 0.185
  7. Matrix metalloproteinase 9-mediated intracerebral hemorrhage induced by cerebral amyloid angiopathy. Neurobiol Aging. 2015 Nov; 36(11):2963-2971.
    View in: PubMed
    Score: 0.162
  8. Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models. Acta Neuropathol. 2013 Sep; 126(3):353-64.
    View in: PubMed
    Score: 0.140
  9. Cerebrovascular lesions induce transient ß-amyloid deposition. Brain. 2011 Dec; 134(Pt 12):3697-707.
    View in: PubMed
    Score: 0.126
  10. Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice. J Neurochem. 2009 Jun; 109(6):1636-47.
    View in: PubMed
    Score: 0.105
  11. Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol. 2007 Mar; 64(3):431-4.
    View in: PubMed
    Score: 0.091
  12. Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease. J Neurosci. 2006 Jan 11; 26(2):365-71.
    View in: PubMed
    Score: 0.084
  13. Alzheimer disease's double-edged vaccine. Nat Med. 2003 Apr; 9(4):389-90.
    View in: PubMed
    Score: 0.069
  14. Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA): Cerebrovascular disease and the failure of elimination of Amyloid-ß from the brain and retina with age and Alzheimer's disease-Opportunities for Therapy. Alzheimers Dement (Amst). 2020; 12(1):e12053.
    View in: PubMed
    Score: 0.057
  15. Histopathology of diffusion-weighted imaging-positive lesions in cerebral amyloid angiopathy. Acta Neuropathol. 2020 05; 139(5):799-812.
    View in: PubMed
    Score: 0.056
  16. Secondary Bleeding During Acute Experimental Intracerebral Hemorrhage. Stroke. 2019 05; 50(5):1210-1215.
    View in: PubMed
    Score: 0.053
  17. Blood-Brain Barrier Leakage and Microvascular Lesions in Cerebral Amyloid Angiopathy. Stroke. 2019 02; 50(2):328-335.
    View in: PubMed
    Score: 0.052
  18. Reducing available soluble ß-amyloid prevents progression of cerebral amyloid angiopathy in transgenic mice. J Neuropathol Exp Neurol. 2012 Nov; 71(11):1009-17.
    View in: PubMed
    Score: 0.034
  19. Differential recognition of vascular and parenchymal beta amyloid deposition. Neurobiol Aging. 2011 Oct; 32(10):1774-83.
    View in: PubMed
    Score: 0.027
  20. Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain. 2007 Sep; 130(Pt 9):2310-9.
    View in: PubMed
    Score: 0.023
  21. Antibody-mediated clearance of amyloid-beta peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging. J Neurosci. 2007 Feb 21; 27(8):1973-80.
    View in: PubMed
    Score: 0.023
  22. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis. 2006 Dec; 24(3):516-24.
    View in: PubMed
    Score: 0.022
  23. Effects of apoE isoforms on beta-amyloid-induced matrix metalloproteinase-9 in rat astrocytes. Brain Res. 2006 Sep 21; 1111(1):222-6.
    View in: PubMed
    Score: 0.022
  24. Progression of cerebral amyloid angiopathy in transgenic mouse models of Alzheimer disease. J Neuropathol Exp Neurol. 2005 Jul; 64(7):588-94.
    View in: PubMed
    Score: 0.020
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.